Supply chain management
The American Hospital Association (AHA) provides resources on supply chain management, the management of health care supplies manufacturing, distribution, delivery, utilization, and replacement.
The Food and Drug Administration June 16 announced that a nationwide shortage of stereotactic breast biopsy needles is expected to last through the end of March 2027.
The Administration for Strategic Preparedness and Response June 16 announced the launch of the Digital Stockpile and Manufacturing Response Network Challenge, a three-phase competition to improve the rapid domestic production of key medical supplies for emergencies.
The U.S. Trade Representative yesterday announced plans to impose additional tariffs on goods from certain nations that it said had lacked or failed to enforce a ban on goods produced with forced labor. The agency reached the conclusion following an investigation under…
The Food and Drug Administration announced May 6 that it is aware of a shortage of neurosurgical patties, sponges and strip devices across the U.S. due to supplier issues, and expects the issue to continue through the end of the year.
The Health Sector Coordinating Council’s Cybersecurity Working Group has released a guide on third-party artificial intelligence risk and AI supply chain transparency.
The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ingredients.
The AHA and its Association for Health Care Resource & Materials Management (AHRMM) today released a new report, Strategic Mapping of Critical Products: Insights for Health Care Leaders, designed to support more informed, proactive decision-making by modeling risk across critical product…
AHA makes recommendations to CMS on strengthening domestic supply chain for PPE, essential medicines
The AHA today submitted comments to the Centers for Medicare & Medicaid Services on an advanced notice of proposed rulemaking on potential options to strengthen the supply chain for American-made personal protective equipment and essential medicines.
AHA comments on the Centers for Medicare & Medicaid Services’ advance notice of proposed rulemaking on potential options to foster a more resilient supply chain for American-made personal protective equipment and essential medicines.
The Administration for Strategic Preparedness and Response March 24 announced an investment to expand the domestic manufacturing of propofol and metoprolol.